3 Top Diabetes Biotechs to Buy Into Right Now Post author:Sam Post published:November 26, 2017 Post category:BioPharma Diabetes is huge problem for Americans. Source: BioSpace You Might Also Like Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B February 19, 2018 AstraZeneca Unloads Four NDAs to ANI Pharmaceuticals in $46.5M Deal December 28, 2017 Relay Therapeutics Lands $63M to Push Its Cancer Candidates Into Clinic December 13, 2017
Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B February 19, 2018
